Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients

Mostrar otras versiones (1)

OBJECTIVE: To evaluate the rate of thrombosis, bleeding and mortality comparing anticoagulant doses in critically ill COVID-19 patients. DESIGN: Retrospective observational and analytical cohort study. SETTING: COVID-19 patients admitted to the intensive care unit of a tertiary hospital between Marc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabara, C., Solarat, B., Castro, P., Fernández, S., Badia, J.R., Toapanta, D., Schulman, S., Reverter, J.C., Soriano, A., Moisés, J., Aibar, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. and SEMICYUC. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617640/
https://www.ncbi.nlm.nih.gov/pubmed/34345092
http://dx.doi.org/10.1016/j.medine.2021.07.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617640/
https://www.ncbi.nlm.nih.gov/pubmed/34345092
http://dx.doi.org/10.1016/j.medine.2021.07.006

Ejemplares similares